Harnessing the patient voice in prostate cancer research: Systematic review on the use of patient-reported outcomes in randomized controlled trials to support clinical decision-making.
Mieke Van HemelrijckFrancesco SparanoLisa MorisKatharina BeyerFrancesco CottoneMirjam SprangersFabio EfficacePublished in: Cancer medicine (2020)
Many PRO trials are currently not included in the EAU guidelines. Our findings suggest that there has to be a better consensus on the use of PRO data for PCa patients, which will then be reflected in the PCa Guidelines and future data collection. Homogeneity in PROs collection and measurement tools will in turn enable "big data" Consortia to increase the patients' voice in clinical research.
Keyphrases
- big data
- patient reported outcomes
- prostate cancer
- systematic review
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- randomized controlled trial
- machine learning
- artificial intelligence
- decision making
- peritoneal dialysis
- clinical trial
- electronic health record
- meta analyses
- deep learning
- case report
- living cells
- fluorescent probe